Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo
- 1 April 2015
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 135 (4) , 1080-1088
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Vitiligo: interplay between oxidative stress and immune systemExperimental Dermatology, 2013
- Vitiligo-Inducing Phenols Activate the Unfolded Protein Response in Melanocytes Resulting in Upregulation of IL6 and IL8Journal of Investigative Dermatology, 2012
- A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the SkinJournal of Investigative Dermatology, 2012
- Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-AnalysesDermatology and Therapy, 2012
- Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune PathogenesisJournal of Investigative Dermatology, 2012
- HSP70i is a critical component of the immune response leading to vitiligoPigment Cell & Melanoma Research, 2011
- Molecular mechanisms underlying the inhibition of IFN‐γ‐induced, STAT1‐mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRsJournal of Cellular Biochemistry, 2010
- The burden of skin diseases: 2004Journal of the American Academy of Dermatology, 2006
- Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial DiseasePLOS Genetics, 2006
- Murine Cutaneous Mastocytosis and Epidermal Melanocytosis Induced by Keratinocyte Expression of Transgenic Stem Cell FactorJournal of Experimental Medicine, 1998